IRIS
CANTONI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.692
Totale 11.692
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.692
Totale 11.692
Salva come PNG Salva come JPEG
Città #
Genova 9.136
Rapallo 1.048
Genoa 850
Vado Ligure 638
Bordighera 20
Totale 11.692
Salva come PNG Salva come JPEG
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 188
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 167
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 167
Role of the calpain-calpastatin system in the density-dependent growth arrest 157
Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation. 150
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 148
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 143
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 143
Effect of tumor cells and tumor microenvironment on NK-cell function. 140
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 139
A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. 138
Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a 138
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 137
null 135
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 130
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. 130
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 130
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 129
Induction of anti-tumor immune response by bispecific monoclonal antibodies (bimAbs). 128
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 127
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 127
A novel type of GABA receptor in rat spinal cord? 127
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis 125
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 125
HLA class-I-specific NK receptors belong to two distinct molecular families and display inhibitory or activating function. 124
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 124
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 124
DNAM-1 and PVR regulate monocyte migration through endothelial junctions 123
P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily. 123
Characterization of human afferent lymph dendritic cells from seroma fluids. 123
Molecular structures of HLA-specific human NK cell receptors. 121
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 121
Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cells. 119
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 118
Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells 118
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 117
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 117
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. 116
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 116
null 116
Physical and functional association of CD45 and CD3-TCR complex on CD1+ human thymocytes. Evidence that the engagement of CD45 molecules can prevent CD1+ thymocytes from apoptosis. 115
Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity. 114
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing 114
Human natural killer cell function and receptors. 113
Identification of the rat homologue of the human NKp46 triggering receptor 113
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 112
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 111
The three-dimensional structure of NK cell receptor NKp44, a triggering partner in natural cytotoxicity 110
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 110
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 108
Phenotypic, functional and molecular analysis of CD3- LGL expansions indicates a relationship to two different CD3- normal counterparts. 108
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily 107
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 106
Crystal structure of the extracellular domain of the human natural killer cell activating receptor NKp44 105
Human natural killer cell receptors: insights into their molecular function and structure 105
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 104
Human natural killer cell receptors and co-receptors. 102
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 102
Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30 102
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 101
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 101
Effect of Melanoma-derived Fibroblasts on NK Cell Phenotype and Functions 101
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. 101
Role of NK cells in immunotherapy and virotherapy of solid tumors 100
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 100
Human NK cells and their receptors 99
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 99
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 99
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. 97
Human natural killer cell activating receptors. 97
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity 97
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 96
null 96
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells 95
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 94
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor 93
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. 93
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 92
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. 92
Cultured human NK cells express the Ki-1/CD30 antigen. 91
null 91
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 91
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules. 90
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 89
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. 88
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 85
The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or disfunction of triggering receptors involved in natural cytotoxicity. 84
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 84
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. 83
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 82
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 82
Identification, molecular cloning and functional characterization of NKp46 and NKp30 Natural Cytotoxicity Receptors in Macaca fascicularis (Macaca Rhesus) NK cells 81
Human decidua contains NK cell committed CD34+ hematopoietic precursors able to differentiated into functional Natural Killer cells 81
Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. 81
MELANOMA CELLS INTERFERE WITH THE ACTIVITY OF NK CELLS BY MODULATING THEIR PHENOTYPE AND CYTOTOXIC FUNCTION 80
The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. 79
Molecular and functional characterization of NKG2D, NKp80 and NKG2C triggering NK cell receptors in Rhesus and Cynomolgus macaques: monitoring of NK cell function during SIV/HIV infection 79
Natural killer cells in pregnancy: how they may avoid their attack to fetal tissues 78
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 78
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 78
Totale 11.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.470
article - articoli 32.839
book - libri 0
conference - conferenze 1.208
curatela - curatele 0
other - altro 0
patent - brevetti 364
selected - selezionate 0
volume - volumi 59
Totale 68.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.759 0 0 0 0 321 368 489 251 315 557 339 119
2020/2021979 57 113 108 83 45 95 48 78 83 101 91 77
2021/20221.419 59 111 132 170 60 75 75 334 54 121 68 160
2022/20231.265 126 81 14 145 205 244 0 86 195 4 152 13
2023/2024644 24 76 17 92 75 101 23 41 52 20 43 80
2024/2025662 37 155 108 149 213 0 0 0 0 0 0 0
Totale 11.930